CLINICAL_TRIALS
trial_result
· 2018-07-26
Clinical Trial Update: A Study of Multiple Doses of LY2922470 in Participants With Diabetes [Phase 1]
Summary
Phase 1 trial evaluating multiple doses of LY2922470 in participants with type 2 diabetes has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2018-07-26